🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHeadaches on GLP-1 — my results so far Page 2

Headaches on GLP-1 — my results so far

TomFromTexas Sat, Apr 26, 2025 at 5:27 AM 40 replies 2,310 viewsPage 2 of 8
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Apr 26, 2025 at 2:38 PM#6
Dr.RaviCardio said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

19 14BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 16 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Apr 26, 2025 at 6:16 PM#7

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

18 13InsuranceTom, WendyG_ATL, SaraMom3 and 15 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Apr 26, 2025 at 9:54 PM#8
DebRD_ATL said:
I dislike how confidently this board tells people to push through.

Coming at DebRD_ATL’s question from a different direction. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Ask again with the specifics and you will get a better answer than this one.

17 12AmyNC_wife, SkepticalSean, Dr.CardioMD and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Apr 27, 2025 at 1:32 AM#9

Following on from hyun_seoul — and this may be the naive question:

Whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out?

16 11MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 13 others
Reply Quote Save Share Report
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Apr 27, 2025 at 6:57 PM#10

OP back with an update, since a thread like this is useless without one.

Holding the step for six weeks instead of four did it. Same dose, same food, and the nausea that had felt like a wall turned out to be a timing problem.

30 3BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 27 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register